Johnson & Johnson immediately made it presence felt at this year’s J.P. Morgan Healthcare Conference in San Francisco by announcing its latest $2bn bet on the antibody-drug conjugates through its acquisition of Ambrx Biopharma.
JPM 2024: Intuitive And J&J Both Weigh In On Growth For 2024
The two medtech giants – both of which will soon be releasing new robotic systems – spoke about growth targets and opportunities going into 2024.
More from Deals
More from Conferences
• By
Medtech Insight sat down with Anja Streicher, chief marketing officer at Women of Wearables, a global community offering events and education resources to support the femtech industry, to discuss trends in the women's wearables tech market, challenges and innovators pushing the boundaries.
• By
Wearable technology must address women’s unique needs, said Anja Streicher, Women of Wearables chief marketing officer. Samphire Neuroscience and Amira Health demo wearable solutions for PMS and hot flashes at Wired Health.
• By
The International Medical Device Regulators Forum discussed AI regulation, the development of a reliance playbook, and post-market regulation at the group's annual meeting in Tokyo last week. While the US FDA was not on-site, the agency was able to participate virtually.